Other OTC - Delayed Quote USD

Integrated BioPharma, Inc. (INBP)

0.2150 0.0000 (0.00%)
At close: April 9 at 11:42 AM EDT
Loading Chart for INBP
DELL
  • Previous Close 0.2150
  • Open 0.1806
  • Bid --
  • Ask --
  • Day's Range 0.2150 - 0.2150
  • 52 Week Range 0.1700 - 0.3800
  • Volume 600
  • Avg. Volume 3,216
  • Market Cap (intraday) 6.471M
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date May 6, 2024 - May 10, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

www.ibiopharma.com

141

Full Time Employees

June 30

Fiscal Year Ends

Recent News: INBP

Performance Overview: INBP

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INBP
14.00%
S&P 500
6.33%

1-Year Return

INBP
40.28%
S&P 500
22.70%

3-Year Return

INBP
80.09%
S&P 500
21.33%

5-Year Return

INBP
43.33%
S&P 500
72.88%

Compare To: INBP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INBP

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    6.47M

  • Enterprise Value

    8.01M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.13

  • Price/Book (mrq)

    0.35

  • Enterprise Value/Revenue

    0.16

  • Enterprise Value/EBITDA

    33.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.76%

  • Return on Assets (ttm)

    -0.93%

  • Return on Equity (ttm)

    -2.07%

  • Revenue (ttm)

    50.52M

  • Net Income Avi to Common (ttm)

    -385k

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    732k

  • Total Debt/Equity (mrq)

    12.25%

  • Levered Free Cash Flow (ttm)

    699.38k

Company Insights: INBP

People Also Watch